Rol de los genes ACE2 y TMPRSS2 en la susceptibilidad o gravedad de la COVID-19
Resumen
Palabras clave
Referencias
Hui DS, Azhar EI, Kim YJ, et al. Middle East respiratory syndrome coronavirus: risk factors and determinants of primary, household, and nosocomial transmission. Lancet Infect Dis. 2018;18:e217-e227. DOI: 10.1016/S1473-3099(18)30127-0.
Guarner J. Three emerging coronaviruses in two decades: the story of SARS, MERS, and now COVID-19. Am J Clin Pathol 2020;153(4):1-2. DOI: 10.1093/ajcp/aqaa029.
Hussin A. Rothana, Siddappa N. Byrareddy. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. Journal of Autoimmunity 2020. DOI: 10.1016/j.jaut.2020.102433.
Ministerio de Salud Pública de Cuba. Parte de cierre del dÃa 19 de abril a las 12 de la noche; 2020 [citado 20 de abril 2020]. Disponible en URL: https://salud.msp.gob.cu/?p=4864.
Lai C-C, Liu YH, Wang C-Y, Wang Y-H, Hsueh S-C, Yen M-Y, et al. Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths. J Microbiol Immunol Infect. 2020; S1684-1182(20)30040-2. DOI: 10.1016/j.jmii.2020.02.012.
Jin J-M, Bai P, He W, Wu F, Liu X-F, Han D-M, et al. Gender differences in patients with COVID-19: focus on severity and mortality. medRxiv preprint, 2020. DOI: 10.1101/2020.02.23.20026864.
Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020; 395:565-574. DOI: 10.1016/S0140- 6736(20)30251-8.
Hoffmann M, Kleine-Weber H, Schroeder S, Kruger N, Herrler T, Erichsen S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 2020; 181:1-10. DOI: 10.1016/j.cell.2020.02.052
Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020; 579: 270-273. DOI: 10.1038/s41586-020-2012-7.
Li W, Zhang C, Sui J, Kuhn JH, Moore MJ, Luo S, et al. Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2. EMBO J. 2005; 24:1634-1643. DOI: 10.1038/sj.emboj.7600640.
Liu T, Hu J, Kang M, Lin L, Zhong H, Xiao J, et al. Transmission dynamics of 2019 novel coronavirus (2019-nCoV). The Lancet 2020. DOI: 10.1101/2020.01.25.919787.
Ceraolo C, Giorgi FM. Genomic variance of the 2019-nCoV coronavirus. J Med Virol 2020; 92:522-528. DOI:10.1002/jmv.25700.
Cao Y, Li L, Feng Z, Wan S, Huang P, Sun X, et al. Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populations. Cell Discovery 2020; 6:11. DOI: 10.1038/s41421-020- 0147-1.
Benetti E, Rossella T, Spiga O, Ciolfi A, Birolo G, Bruselles A, et al. ACE2 variants underlie interindividual variability and susceptibility to COVID-19 in Italian population. medRxiv preprint DOI: 10.1101/2020.04. 03.20047977.
Asselta R, Paraboschi EM, Mantovani A, Duga S. ACE2 and TMPRSS2 variants and expression as candidates to sex and country differences in COVID-19 severity in Italy. medRxiv preprint, 2020. DOI: 10.1101/2020.03.30.20047878.
Chaoxin J, Daili S, Yanxin H, Ruwei G, Chenlong W, Yaobin T. The influence of angiotensin-converting enzyme 2 gene polymorphisms on type 2 diabetes mellitus and coronary heart disease. Eur Rev Med Pharmacol Sci. 2013; 17: 2654-9.
Yang M, Zhao J, Xing L, Shi L. The association between angiotensin-converting enzyme 2 polymorphisms and essential hypertension risk: A meta-analysis involving 14,122 patients. J Renin Angiotensin Aldosterone Syst. 2015; 16: 1240-4. DOI: 10.1177/1470320314549221.
Zhao Y, et al. Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCoV. bioRxiv, 2020. DOI: 10.1101/ 2020.01.26.919985.
Chen J, Jiang Q, Xia X, Liu K, Yu Z, Tao W, et al. Individual variation of the SARS-CoV2 receptor ACE2 gene expression and regulation. Preprints 2020.
Cai G. Bulk and single-cell transcriptomics identify tobacco-use disparity in lung gene expression of ACE2, the receptor of 2019-nCov. medRxiv 2020. DOI: 10.1101/2020.02.05.20020107.
Enlaces refback
- No hay ningún enlace refback.

Este obra está bajo una licencia de Creative Commons Reconocimiento-NoComercial 4.0 Internacional.